Glucose control in pancreas transplantation assessed by 72-hr continuous glucose monitoring

Transplantation

Volumn 94, Issue 1, 2012, Pages

  Lauria, Márcio W ^a,b   Figueiró, José Maria ^b   Sanches, Marcelo D ^a   Gontijo, Ricardo C ^b   Mariano, Bernardo A ^a   Lana, Ángela Maria Q ^a   Ribeiro Oliveira, Antônio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Felicio Rocho Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PREDNISONE; TACROLIMUS;

ADULT; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; LETTER; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; THERAPY EFFECT;

ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TIME FACTORS;

EID: 84863711298     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/Tp.0b013e31825d691     Document Type: Letter

References (9)

1. Battezzati A, Benedini S, Caldara R, et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001; 71: 1560.
2. Pfeffer F, Nauck MA, Drognitz O, et al. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 2003; 76: 1427.
3. Elmer DS, Hathaway DK, Bashar Abdulkarim A, et al. Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 1998; 12: 56.
4. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and non diabetic kidney transplant recipients. Diabetes 1994; 43: 593.
5. Wong JJ, Krebs TL, Klassen DK, et al. Sonographic evaluation of acute pancreatic transplant rejection: morphology-Doppler analysis versus guided percutaneous biopsy. AJRAm J Roentgenol 1996; 166: 803.
6. Abendroth D, Capalbo M, Ilner WD, et al. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage. Transplant Proc 1992; 24: 786.
7. Kessler L, Passemard R, Oberholzer J, et al. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care 2002; 25: 2256.
8. Gorn L, Faradji RN, Messinger S, et al. Impact of islet transplantation on glycemic control as evidenced by a continuous glucose monitoring system. J Diabetes Sci Technol 2008; 2: 221.
9. Faradji RN, Monroy K, Riefkohl A, et al. Continuous glucose monitoring system for early detection of graft dysfunction in allogenic islet transplant recipients. Transplant Proc 2006; 38: 3274.